Clinitech Laboratory Complete Financial Statements
CTLLAB • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021
Complete Financial Data Export
Export complete financial statements for Clinitech Laboratory (CTLLAB).
Downloads include all available records across all periods.
For market performance, see the
CTLLAB stock price today
.
Profitability Ratios
EBITDA Margin
11.11%
2025 data
Operating Margin
10.00%
2025 data
Balance Sheet Ratios
Debt to Equity
1.22
2025 data
Equity Ratio
81.82%
2025 data
Asset Turnover
0.82
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+83.3%
Year-over-Year
Equity Growth
+125.0%
Year-over-Year
Liabilities Growth
+83.3%
Year-over-Year
Investing Cash Flow Growth
-200.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 9 | 6 | 6 | 7 | 5 |
| Expenses | 0 | 7 | 5 | 5 | 5 | 4 |
| EBITDA | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit Margin % | 0.00% | 10.00% | 16.00% | 21.00% | 17.00% | 18.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 0 |
| Earnings Per Share (₹) | 0.00 | 1.90 | 2.37 | 4.09 | 3.42 | 6.04 |
Related Pages for Clinitech Laboratory
Additional stock information and data for CTLLAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 11 | 6 | 6 | 4 | 3 |
| Current Assets | 7 | 3 | 2 | 1 | 2 |
| Fixed Assets | 2 | 2 | 1 | 2 | 1 |
| Capital Work in Progress | 1 | 1 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 3 | 4 | 2 | 2 |
| LIABILITIES | |||||
| Total Liabilities | 11 | 6 | 6 | 4 | 3 |
| Current Liabilities | 0 | 0 | 2 | 1 | 1 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 9 | 4 | 2 | 2 | 1 |
| Share Capital | 2 | 2 | 2 | 2 | 1 |
| Reserves & Surplus | 7 | 2 | 1 | 0 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | 1 | 1 | 0 |
| Investing Activities | -1 | 1 | -1 | -2 | 1 |
| Financing Activities | 4 | 0 | 0 | 0 | -1 |
| Net Cash Flow | 2 | 0 | 1 | 0 | 0 |